Blueprint Medicines Corporation ( NASDAQ: BPMC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET ...

MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 Zug, Switzerland, April 25, 2025 - MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company ...

As ALS weakened him with one demoralizing defeat after another, McMichael realized he was in a battle he could prolong but ...

ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission ...

Finally, random chart ... patient safety concerns reached the same conclusion.68 What's missing from these estimates are true incidence data, as typically the denominators are not available or ...

The pharmacists reviewed patients' medical charts ... The severity of the incidents was categorised as significant, serious, life-threatening or fatal using a methodology developed by the Brigham and ...

An abbreviated investigation flow chart is shown in figure 1 and an abbreviated treatment ... Factors to be taken into account include the severity and recurrent nature of the anaemia, the risk of ...

Management highlighted continued focus on rate increases and underwriting adjustments in Casualty lines to address rising auto severity. Rate increases of 15% for personal umbrella and 17% for ...

The U.S. consumer product safety agency will stop collecting data on injuries from incidents like car accidents and adverse ...

Here's Seattle's projected safety depth chart to begin the 2025 season. Note: Macdonald has stated in the past that his scheme doesn't use the typical "free safety" and "strong safety" positions.

On April 11, 2025, the Centers for Medicare & Medicaid Services (“CMS”) published its annual proposed rule for the federal fiscal year (“FFY”) ...